Loading...
DOCUMENTS
98
NOTICES
156
MOTS CLES
Adalimumab
Biosimilar Pharmaceuticals
Antimicrobiens
Epidemiology
Beta-lactam antibiotics
Alitretinoin
Biomarkers
Sipuleucel-T
Ankylosing
Endocrine toxicity
Antimicrobial Stewardship
Axial spondyloarthritis
Placebo
Ethics
Systematic review
Adverse side effects
Etanercept
Psoriasis
Amyloidosis
Anxiety
Arrhythmia
Drug reaction
Ankylosing spondylitis
Pregnancy
Accelerometer
Stability
Antibiotic misuse
Network meta-analysis
Apremilast
Immune checkpoint inhibitors
Addiction
Bacterial
Burden
Pharmacoepidemiology
Adolescent
Access to care
Drug survival
Apre-milast
Aging
Auto-Diagnostic
Psoriatic arthritis
Sacroiliitis
Antibiotic resistance
Biologics
Alcohol
COVID-19
Anticancer drugs
Spondylitis
Biomédicaments
Azathioprine
Pharmacovigilance
Dermatology
Vigibase®
Meta-Analysis
Infliximab
BTK protein
Biologic drug
Atopic dermatitis
Quality of life
Biological Therapy
Abus d'antibiotiques
Management
Biologic
ArtThese
Arthritis
Auto-immune hepatitis
ASDAS
Biological therapy
Anti-HCV Direct Acting Antivirals DAA
Autoimmunity
Glucocorticoids
Autoimmune diseases
Graft-versus-host disease
Treatment
Angiotensin-converting enzyme inhibitors
Primary adrenal insufficiency
Acute Myeloid Leukaemia AML
Antimicrobial resistance
Antimicrobials
Cardiomyopathy
Cancer
Antibiotics
Cardiotoxicity
Immunotherapy
Atrial fibrillation
Immune-related adverse events
Prostate cancer
Anti-TNF
Angiotensin receptor blockers
Anxiété
Méta-Analyse
Spondyloarthritis
Ustekinumab
Anti-Bacterial Agents
Bacterial rhinosinusitis
Biologic therapy
Albinism
Pharmaco-Épidémiologie
Cardio-oncology
Intensive care
Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379 | |
---|---|
Adresse |
Université Paris-Est Créteil Val de Marne (UPEC) Campus Centre de Créteil |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Émilie SBIDIAN |
Axe(s) de recherche
|
|
COLLABORATIONS
|